Quantitative LC-ToF MS analyses of dried blood spots: Developing an assessment of medication adherence for heart disease patients

Simple item page
dc.contributor.authorBernieh, Dennisen
dc.contributor.authorLawson, Grahamen
dc.contributor.authorTanna, Sangeetaen
dc.date.accessioned2015-09-16T08:30:11Z
dc.date.available2015-09-16T08:30:11Z
dc.date.issued2015-09-07
dc.description.abstractIntroduction: Over 355 million prescriptions were dispensed for cardiovascular diseases in the UK in 20131. Half of these, costing the NHS £2.3 billion, were wasted because patients did not take their medicines as prescribed2. A method using dried blood spot (DBS) sample collection followed by liquid chromatography-time of flight mass spectrometry (LC-ToF MS) analyses3,4 was developed and validated for quantification of 8 commonly UK prescribed cardiovascular drugs: atenolol, bisoprolol, diltiazem, doxazosin, losartan, ramipril, simvastatin and valsartan. Thus medication effectiveness, adherence or drug/drug interactions can be assessed from reference pharmacokinetic data. Methods: For the preparation of DBS calibration samples whole blood was spiked with 8 target analytes to produce 30µl blood spots on specimen cards. 8mm disc was punched out and extracted with methanol:water (70:30v/v) containing the internal standard, atenolol D7. Chromatography analysis was performed using gradient elution with a run time of 2.5 min. High resolution MS detection was carried out using electrospray positive ion mode for all target analytes and internal standard. Results: The LC-ToF MS method validation showed good linearity and the accuracy (relative error) and precision (coefficient of variation) values were within the pre-defined limits of ≤15% at all tested concentrations for the 8 target drugs. Drug recoveries from spiked blood spots were ≥ 82% for atenolol, bisoprolol, diltiazem, doxazosin, losartan, ramipril and valsartan. Results from DBS samples from volunteers were within expected levels with respect to published pharmacokinetic data except where elevated levels indicated a recognised drug/drug interaction. Conclusions: Quantitative DBS analyses using LC-ToF MS has the potential to both assess medication adherence and to allow re-interrogation of data collected for heart disease patients.en
dc.funderDMU bursaryen
dc.identifier.citationBernieh, S., Lawson, G. and Tanna, S. (2015) Quantitative LC-ToF MS analyses of dried blood spots: Developing an assessment of medication adherence for heart disease patients. Proceedings of the 21st International Reid Bioanalytical Forum, September 7-10, Guildford, UKen
dc.identifier.urihttp://hdl.handle.net/2086/11202
dc.language.isoenen
dc.peerreviewedYesen
dc.projectidBlood spot analysis researchen
dc.researchinstituteLeicester Institute for Pharmaceutical Innovation - From Molecules to Practice (LIPI)en
dc.subjectdried blood spoten
dc.subjectDBSen
dc.subjectLC-ToF MSen
dc.subjectLC-HRMSen
dc.subjectmedication adherenceen
dc.subjectcardiovascular pharmacotherapyen
dc.titleQuantitative LC-ToF MS analyses of dried blood spots: Developing an assessment of medication adherence for heart disease patientsen
dc.typeConferenceen

Files

License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
4.2 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Leicester School of Pharmacy